DSM-5: New category proposal “Simple Somatic Symptom Disorder”
Post #57 Shortlink: http://wp.me/pKrrB-TA
On 16 January, I reported that the page for current DSM-5 proposals for the revision of the DSM-IV “Somatoform Disorders” categories and diagnostic criteria had been updated on 14 January, with a new category proposal called “Simple Somatic Symptom Disorder”.
This proposal is in addition to the recommendations of the Somatic Symptom Disorders Work Group, published in February 2010, for grouping a number of existing Somatoform categories under a common rubric “Complex Somatic Symptom Disorder (CSSD)” and does not replace “CSSD”.
For full details see previous Post #56: http://wp.me/pKrrB-St
Simple Somatic Symptom Disorder
See Tab: Proposed Revision:
Simple (or abridged) Somatic Symptom Disorder (e.g. pain)
To meet criteria for Simple Somatic Symptom Disorder, criteria A, B, and C are necessary.
A. One or more highly distressign [sic] and disabling somatic symptoms
B. One of the following symptoms from CSSD (i.e. Disproportionate and persistent concerns about the medical seriousness of one’s symptoms; high level of health-related anxiety; or excessive time and energy devoted to these symptoms or health concerns)
C. Symptom duration is greater than 1 month
For full proposals for “Simple Somatic Symptom Disorder” open the Tabs on this page:
Key links and documents associated with the proposals of the Somatic Symptom Disorders Work Group:
DSM-5 Development website: Somatoform Disorders
Proposal: Complex Somatic Symptom Disorder
Proposal: Simple Somatic Symptom Disorder
Update @ 7 February 2011
The Justification of Criteria document was revised again by the SSD Work Group on 1/31/11 to incorporate the proposal for SSSD and other revisions and is replaced by:
Revised Disorder Descriptions: Version 1/14/11
Previous revised Justification of Criteria: Version 10/4/10
I shall be monitoring the DSM-5 Development website and if there are any further revisions to either document before the DSM-5 beta is published I will update this site.
According to the APA’s DSM-5 Development Timeline, the second draft is scheduled to be published by the DSM-5 Task Force in May-June, with a public review period of only around a month. The public review and comment period for the first draft, last year, had been around ten weeks.
The following patient organisations have been alerted to these revisions and sent copies of the key documents:
UK patient organisations:
Heather Walker, Action for M.E.
Neil Riley, Chair, Board of Trustees, ME Association
25% ME Group
Invest in ME
Jane Colby, The Young ME Sufferers Trust
US patient organisations and professionals:
Dr Alan Gurwitt, Massachusetts Chronic Fatigue and Immune Dysfunction Syndrome/Myalgic Encephalopathy and Fibromyalgia Association (Mass. CFIDS/ME & FM)
Dr Kenneth Friedman, IACFS/ME
Jennie Spotila, CFIDS Association of America
Dr Lenny Jason
International patient organisations and professionals:
ESME (European Society for ME)
Dr Eleanor Stein, Canada